- Home
- TOMZ vs COCP Comparison
TOMZ vs COCP Comparison
Compare TOMZ & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOMZ | COCP |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 15.6M |
| IPO Year | 2009 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TOMZ | COCP |
|---|---|---|
| Price | $0.56 | $1.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $6.00 |
| AVG Volume (30 Days) | 50.9K | ★ 4.2M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.64 | ★ 54.65 |
| EPS | ★ N/A | N/A |
| Revenue | $5,635,927.00 | ★ $12,712,091.00 |
| Revenue This Year | $111.50 | N/A |
| Revenue Next Year | $57.16 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $0.86 |
| 52 Week High | $1.20 | $2.19 |
Technical Indicators
Market Signals| Indicator | TOMZ | COCP |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 75.79 |
| Support Level | $0.54 | $0.95 |
| Resistance Level | $0.81 | $1.95 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 24.66 | 46.61 |
Price Performance
Historical ComparisonAbout TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).